Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...
Early inflation Balloon inflates before aortic valve closes – the left ventricle is therefore forced to empty against an inflated balloon. There is an increase in afterload, potentially raising ...
Continuing the trajectory seen at 30 days and 1 year, the long-term data from the IABP-SHOCK II trial reported today show no survival benefit for intra-aortic balloon pump (IABP) use in acute MI ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
Compared with the years 2000-2009, cardiac deaths and case fatalities in U.S. marathon and half-marathon runners have come down significantly. (JAMA) People with zero of five classic cardiovascular ...
AMSTERDAM, The Netherlands— In patients undergoing early revascularization for myocardial infarction (MI) complicated by cardiogenic shock, use of an intra-aortic balloon pump (IABP) does not reduce ...
PARIS -- Intra-aortic balloon pumps (IABP) didn't significantly improve outcomes for patients with ischemia persisting well after percutaneous coronary intervention (PCI) for a large acute ST-segment ...
In the multicentre, open-label, randomized, controlled trial IABP-SHOCK II, the previously reported 30-day data demonstrated no early mortality reduction with intra-aortic balloon pump (IABP) use in ...
A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used in several million people ...
Please provide your email address to receive an email when new articles are posted on . Teleflex announced FDA clearance for an intra-aortic balloon pump for the treatment of patients with severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results